Resolution of the consensus of Russian Federation experts on the diagnosis and treatment of osteoarthritis for primary care physicians
|
№5 / 2022
|
Bashkova I.B., Busalaeva E.I.
The level of awareness of beginner district therapists about the management of patients with primary osteoarthritis
|
№2 (приложение) / 2022
|
Nesterenko V.A., Karateev A.E.
New possibilities of local injection therapy in complex treatment of skeletal and muscular pain
|
№2 / 2022
|
Gaydukova I.Z., Mazurov V.I.
Topical non-steroidal anti-inflammatory drugs in treatment of osteoarthritis
|
№8 / 2020
|
Eliseeva l.N., Kartashova S.V.
Mexidol® and mexidol® forte 250 in consecutive therapy of cognitive disorders in comorbid patients with joint pathology on the background of arterial hypertension and ischemic heart disease
|
№6 / 2020
|
Pilipovich A.A., Danilov Al.B.
Osteoarthritis pain: pathogenesis and modern possibilities of therapy
|
№3 / 2020
|
Shapovalova D.A., Tyurin A.V., Khusainova R.I.
Study of locuses associated with osteoarthritis on the basis of the results of full genomic investigations (GWAS) among women from Bashkortostan
|
№7 / 2019
|
Dydykina I.S., Nurbaeva K.S., Kovalenko P.S., Zotkin E.G.
Musculoskeletal system pathology: substantiation of the possibility of undenaturated collagen type ii including in complex treatment of knee joints osteoarthritis
|
№6 / 2019
|
Trofimov E.A., Mazurov V.I., Melnikov E.S.
Combined drug therapy of post-traumatic osteoarthritis
|
№6 / 2019
|
Mezenova T.V.
Osteoarthritis: risk factors and treatment options
|
№1 / 2019
|
P.R. Kamchyatnov, A.V. Chugunov, S.B. Khanmurzaeva, N.B. Khanmurzaeva
Use of structural-modifying medicaments for lumbal pain patients
|
№7 / 2017
|